{
"NDC": {
"NDCCode": "45932-0039-1",
"PackageDescription": "1 VIAL in 1 CARTON (45932-0039-1) > 7 mL in 1 VIAL",
"NDC11Code": "45932-0039-01",
"ProductNDC": "45932-0039",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Daptomycin",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Daptomycin",
"DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20180719",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA209949",
"LabelerName": "Xellia Pharmaceuticals USA, LLC",
"SubstanceName": "DAPTOMYCIN",
"StrengthNumber": "350",
"StrengthUnit": "mg/7mL",
"Pharm_Classes": "Lipopeptide Antibacterial [EPC],Lipopeptides [CS]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2021-01-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20201231",
"StartMarketingDatePackage": "20180719",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}